Tobio Novelfarma

Founded in 2015, Tobio Novelfarma is a fast growing, dynamic, innovative pharmaceutical company focused on developing innovative medicines to satisfy the unmet needs of patients both in domestic and international markets. Tobio Novelfarma has a wide product portfolio offering treatment options in genetic and rare diseases, oncology, dermatology, paediatric diseases and gastro intestinal system diseases. Tobio Novelfarma has a strong a R&D team targeted to develop innovative products with the capability of developing high number of projects. Tobio Novelfarma maintains sustainability by continuous investment in R&D projects. Its success results from combining an entrepreneurial spirit, operational excellence and a strong ambition for continued growth. Tobio Novelfarma supports excessive innovation collaborating with prominent universities, public research institutions, and partner companies. By investing in R&D, Tobio Novelfarma targets to develop high quality, safe & effective, easy to use, affordable products. Tobio Novelfarma believes establishing long term relations with its partner companies offering them different business models including finished product supply, co-development opportunities and licensing out of its Products.